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Adult-to-adult living donors and recipients were studied to characterize patterns of liver growth and identify associated fac-
tors in a multicenter study. Three hundred and fifty donors and 353 recipients in the Adult-to-Adult Living Donor Liver Trans-
plantation Cohort Study (A2ALL) receiving transplants between March 2003 and February 2010 were included. Potential
predictors of 3-month liver volume included total and standard liver volumes (TLV and SLV), Model for End-Stage Liver Dis-
ease (MELD) score (in recipients), the remnant and graft size, remnant-to-donor and graft-to-recipient weight ratios (RDWR
and GRWR), remnant/TLV, and graft/SLV. Among donors, 3-month absolute growth was 6766 251 g (mean6SD), and per-
centage reconstitution was 80%6 13%. Among recipients, GRWR was 1.3%60.4% (8< 0.8%). Graft weight was
60%6 13% of SLV. Three-month absolute growth was 5496 267 g, and percentage reconstitution was 93%618%. Predic-
tors of greater 3-month liver volume included larger patient size (donors and recipients), larger graft volume (recipients),
and larger TLV (donors). Donors with the smallest remnant/TLV ratios had larger than expected growth but also had higher
postoperative bilirubin and international normalized ratio at 7 and 30 days. In a combined donor-recipient analysis, donors
had smaller 3-month liver volumes than recipients adjusted for patient size, remnant or graft volume, and TLV or SLV
(P5 0.004). Recipient graft failure in the first 90 days was predicted by poor graft function at day 7 (HR5 4.50, P50.001)
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but not by GRWR or graft fraction (P>0.90 for each). Both donors and recipients had rapid yet incomplete restoration of
tissue mass in the first 3 months, and this confirmed previous reports. Recipients achieved a greater percentage of
expected total volume. Patient size and recipient graft volume significantly influenced 3-month volumes. Importantly, donor
liver volume is a critical predictor of the rate of regeneration, and donor remnant fraction affects postresection function.
Liver Transpl 21:79-88, 2015. VC 2014 AASLD.
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Liver regeneration is critical in adult living donor liver
transplantation (LDLT), and size considerations affect
the selection of appropriate donor and recipient
pairs.1,2 Single-center studies have shown that recipi-
ents have rapid liver regeneration but that many
donors do not regain total liver volume, even after 1
year.3-6 Portal hemodynamics, vascular outflow, graft-
to-recipient weight ratios (GRWR), humoral factors, and
graft quality have all been implicated in affecting liver
regeneration. Left lobe donors provide even smaller
grafts, and makes the procedure potentially safer for
the donor but increases the risk for the recipient.7,8
A principal aim of the Adult-to-Adult Living Donor
Liver Transplantation Cohort Study (A2ALL) is to char-
acterize liver regeneration and function and their
impact on outcomes in both donors and recipients.
This is the first multicenter study examining the clini-
cal manifestations of liver regeneration in LDLT and
characterizing growth patterns common to donors and
recipients with a prospectively defined clinical cohort.
PATIENTS AND METHODS
Data Sources
Study Population
A2ALL enrolled potential living donors and their recipi-
ents at 9 participating transplantation centers. Trans-
plantations occurred betweenMarch 2003 and February
2010, with follow-up through August 2010. Donors had
preoperative volumetric imaging by magnetic resonance
imaging (MRI) or computed tomography (CT) to deter-
mine total liver volume (TLV) and right and left lobe vol-
umes. Grafts were weighed (or volumes measured by
displacement) in the operating room (OR) after removal.
Donors and recipients had imaging data at 3 months
after donation/transplantation.9 Volume (cc), as meas-
ured on imaging, and weight (g), as measured in the OR,
are used interchangeably and adjusted for blood that
has drained from the removed lobe. Demographic infor-
mation, clinical variables, and laboratory values were
collected preoperatively and at 3months after transplan-
tation. Preoperative imaging was available in 334 donors
(310 right lobes, 24 left lobes); investigation of remnant
regeneration was limited to 221 (211 right lobes, 10 left
lobes) who also had graft weight (from intraoperative
weight or volume or preoperative imaging) and 3-month
imaged volumes. Graft weights were available for 308
recipients (291 right lobes, 17 left lobes). Investigation of
graft regeneration included 150 (145 right lobes, 5 left
lobes) with 3-month imaged volumes. Among the 158
recipients without 3-month imaging, 24 died or lost their
graft within 3 months [6 died (5 right lobes, 1 left lobe),
16 lost their graft (all right lobes), and 2 lost their grafts
and died (both right lobes)]. There were 127 (122 right
lobes, 5 left lobes) donor-recipient pairs among whom
both had complete volumetric data.
Corrected Graft Volumes
In donors, graft volumes estimated by preoperative
imaging were higher than intraoperative graft weights,
thought to be due primarily to the weight of blood in
vivo.6,8,10 Imaged volume exceeded measured weight
by a mean of 146 g610.6 g (18.6%, P<0.001). To
combine data from intraoperative and imaging meas-
urements, an equation for in vivo graft volume based
on intraoperative graft weight was developed for 253
donors who had data from both sources. The cor-
rected graft volume was estimated as 19810.939*
graft weight (R250.55; Supporting Fig. 1). When the
graft weight was not measured in the OR (n582), the
preoperative imaged graft volume was used.
Volume Measurements
For donors, remnant volume was calculated by sub-
tracting corrected graft volume from TLV. For recipi-
ents, “normal” liver volume was estimated by standard
liver volume [SLV51072.8 3 body surface area (BSA)
– 345.7, where BSA5 [weight (kg)]0.425 3 (height
(cm)]0.725 3 0.007184),9 and liver size at transplant
was defined as corrected graft volume. The liver frac-
tion was defined as the percentage of the “normal”
whole liver volume that the remnant or graft repre-
sented (remnant volume/TLV for donors; corrected
graft weight/SLV for recipients). The GRWR was calcu-
lated from corrected graft weight in the OR and preop-
erative recipient weight. The remnant-to-donor weight
ratio (RDWR) was calculated similarly for donors.
Outcome Measures and Regeneration
Parameters
Imaged 3-month liver volume was the primary outcome
measure, and 3 additional measures of regeneration
were calculated. First, the absolute volume increase in
cubic centimeters was defined as the difference between
the 3-month imaged volume and the graft or remnant
volume. Second, the percentage volume increase was
the percentage increase of liver volume from time of
transplant or resection to 3 months after transplanta-
tion. Third, the percentage reconstitution in cubic centi-
meters was defined as the percentage of the normal
whole liver volume (TLV for donors; SLV for recipients)
achieved by 3 months.
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We chose the 3-month liver volume as the main out-
come of interest because its measurement does not
depend directly on remnant/graft volume. Two of the
other outcomes (absolute and percentage volume
increase) use remnant/graft volume in their calculation,
and this prevents the latter from being a proper inde-
pendent variable in statistical models of these outcomes.
Early allograft dysfunction and small-for-size syn-
drome (SFSS) were defined by the presence of jaun-
dice (bilirubin >10 mg/dL on day 7) or coagulopathy
[international normalized ratio (INR)>1.6 on day 7],
without technical complications as modified from pre-
vious definitions.10-12
Human Subject Protection
The study was approved by the institutional review
boards and privacy boards of the University of Michi-
gan Data Coordinating Center and each of the 9 par-
ticipating transplant centers. All subjects provided
written informed consent. No donor organs were
obtained from executed prisoners or other institution-
alized persons.
Statistical Analyses
Correlation coefficients were used to assess relation-
ships among graft and remnant fractions, measures of
regeneration, and laboratory values. Student t-tests
were used to compare GRWR and liver fraction for
recipients with and without poor function at day 7. Lin-
ear regression was used to identify predictors of 3-
month liver volume separately in donors and recipients,
as well as in a combined model. Potential explanatory
factors were tested based on significant findings in
prior studies.11-17 For associations in donors, donor
sex, age, weight, height, body mass index (BMI), BSA,
TLV, remnant lobe type (left or right), remnant volume,
RDWR, and remnant liver fraction were tested. For
associations in recipients, donor and recipient sex, age,
weight, height, BMI, and BSA; graft lobe type (left or
right), graft weight, GRWR, liver fraction, and cold
ischemia time; and recipient SLV, hepatitis C virus
(HCV) diagnosis, and Model for End-Stage Liver Disease
(MELD) score at transplant were tested.
Analysis of donor and recipient 3-month liver vol-
umes together was restricted to subjects with a range
of liver volumes at transplant common to both groups,
which was 550 to 1200 g (n5106 donors, n5128
recipients). Variables considered for inclusion were
patient type (donor or recipient), lobe type, and varia-
bles significant in the separate models (weight, TLV,
graft or remnant volume, liver fraction). Statistical
interactions between patient type and each of the lat-
ter factors were tested.
Logistic regression was used to test for associations
between incomplete regeneration (defined as <75%
reconstitution of TLV or SLV by 3 months) and 7- and
30-day postoperative albumin, bilirubin, INR, and cre-
atinine. Logistic regression was used to examine the
association between poor function at 7 days and 3-
month liver volume in recipients adjusted for graft
size and patient weight.
We used 3 sets of Cox regression models to investi-
gate predictors of graft failure (including death). The
first set followed patients from transplantation and
tested separately whether graft weight, GRWR, or liver
fraction predicted graft failure overall or in the first 90
Figure 1. Study population and analysis subsets.
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days. The second set followed patients from day 7
after transplantation and tested whether poor func-
tion at day 7 predicted subsequent graft failure overall
or in the first 90 days. The third set followed patients
from day 90 after transplantation and tested sepa-
rately whether absolute growth, volume reconstitu-
tion, or percentage volume increase at day 90
predicted subsequent graft failure.
Among the donor-recipient pairs, correlation coeffi-
cients were used to assess relationships between
paired graft/remnant absolute growth, percentage
reconstitution, percentage volume increase, and 3-
month volume. All analyses were performed in SAS
version 9.2 (SAS Institute, Cary, NC).
RESULTS
Figure 1 shows the available study sample for each
set of results described below.
Baseline Analyses: Donor and Recipient
Characteristics
A total of 334 donors had TLV measurements (Table 1
and Supporting Table 1, by lobe). Mean age was 38
years, approximately half were men, and the majority
were non-Hispanic white and biologically related to
the recipient. Right lobe donors (n5310) differed from
left lobe donors (n524) in mean graft weight (right
TABLE 1. Characteristics of Donors (n5334) and Recipients (n5308)
Donors Recipients
Characteristic n
Mean (SD) or
Percentage Range (or IQR) n
Mean (SD)
or Percentage
Range
(or IQR)
Age at donation or
transplant
(years)
334 38 (10) 20-63 308 52 (11) 18-72
Sex
Male 168 50.3 165 53.6
Female 166 49.7 143 46.4
Ethnicity
Hispanic/Latino 45 13.5 41 13.3
Non-Hispanic/non-Latino 289 86.5 265 86.0
Missing 0 0 2 1.6
Race
White 308 92.2 278 90.3
African American 10 3.0 11 3.6
Asian 5 1.5 6 1.9
Other 11 3.3 11 3.6
Right lobe donor or recipient 310 92.8 289 93.8
Height at evaluation (cm) 332 172 (10) 135-196 302 171 (11) 140-203
Weight at evaluation (kg) 327 78 (15) 47-135 299 78 (17) 40-143
BMI at evaluation (kg/m2) 326 26 (4) 16-41 297 27 (5) 16-48
TLV by Imaging at
evaluation (cc)
or calculated SLV
at transplantation (cc)
334 1566 (298) 1353-1763* 288 1684 (263) 1501-1855*
Graft weight at donation (g)† 334 987 (204) 860-1108* 308 989 (196) 860-1108*
Calculated remnant volume
at donation (g)
334 579 (240) 413-722* — — —
Remnant or graft liver
fraction (%)‡
334 36 (11) 30-42* 288 60 (13) 51-67*
Liver volume at month 3 (cc) 221 1241 (271) 1022-1401* 150 1542 (304) 1338-1743*
Laboratory values at day 7
Bilirubin (IU/L) 334 1.6 (1.4) 0.4-10.6 306 5.0 (5.1) 0.3-36.7
Albumin (g/dL) 280 3.2 (0.4) 1.8-4.5 268 2.8 (0.7) 1.5-5.8
INR 289 1.2 (0.2) 0.9-1.8 232 1.3 (0.2) 0.8-2.4
Laboratory values at day 30
Bilirubin (IU/L) 311 0.7 (0.5) 0.1-5.2 304 2.1 (4.4) 0.1-42.5
Albumin (g/dL) 295 3.8 (0.5) 2.1-5.2 277 3.2 (1.1) 1.4-18.0
INR 262 1.1 (0.1) 0.7-2.6 223 1.2 (1.1) 0.8-17.0
*IQR.
†Measured graft weight in OR corrected by blood.
‡Calculated residual lobe volume/TLV by imaging for donors; graft weight/SLV for recipients.
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lobes, mean 10216187 g; left lobes, 6726146 g;
P<0.001) and the donor remnant size both in weight
(mean 5486213 g after right lobe donation,
9826192 g after left lobe donation, P<0.001) and as
a fraction of TLV (34% versus 59%, P<0.001). Rem-
nant fraction was less than 35% of TLV for 168
donors (50%); it was less than 25% of TLV for 41
(12%) right lobe donors.
The mean age of recipients was 52 years, 54% were
men, and 86% were non-Hispanic white. Left lobe
recipients (n517) were more often female than right
lobe recipients (n5291; 94% versus 44%, P<0.001)
and therefore were also shorter (P<0.001) and lighter
(P50.007). Mean graft volume was 989 cc, with right
lobes averaging 1007 cc and left lobes averaging 685
cc (Table 1 and Supporting Table 2, by lobe). Left lobe
recipient grafts as a fraction of SLV (48% versus 61%,
P50.001) and GRWR (1.1% versus 1.3%, P50.005)
were smaller than right lobe recipient grafts. Eight (6
right, 2 left) grafts had a GRWR <0.8%, and 11 (9
right, 2 left) had a liver fraction less than 40% (7
grafts met both criteria).
Donor and Recipient 3-Month Liver Volumes
and Growth Parameters
Donor remnants had larger absolute growth at 3
months (676 cc) than recipient grafts (553 cc,
P<0.001) but lower percentage reconstitution at 3
TABLE 2. Predictors of 3-Month Liver Volume by Multiple Linear Regression Analysis Among Donors, Among
Recipients, and Among Both Donors and Recipients
Predictor
Effect on Liver
Volume (g) 95% CI P Value
Donor model* (n5221, R250.57)
Weight† (per 10 kg) 43.8 22.0, 65.5 <0.001
TLV (per 100 g) 50.9 38.8, 63.0 <0.001
Remnant liver fraction‡ (per 1%) 10.5 5.8, 15.3 <0.001
Remnant liver fraction‡ squared (per 1%) 0.40 0.25, 0.55 <0.001
Recipient model§ (n5149,jj R250.38)
Weight† (per 10 kg) 71.5 46.5, 96.4 <0.001
Graft volume (per 100 g) 60.5 39.5, 81.4 <0.001
Combined model for donors and recipients¶ (n5232,jj R250.42)#
Donor (versus recipient) 2110.4 2185.0, 235.9 0.004
Weight† (per 10 kg) 44.1 14.3, 73.8 0.004
Remnant or graft volume (per 100 g) 53.9 32.6, 75.3 <0.001
TLV or SLV (per 100 g) 24.4 3.9, 44.8 0.020
*In the donor model, donor sex, age, height, BMI, BSA (see footnote jj below), remnant lobe type (left or right), remnant
volume, and RDWR were tested but were not significant.
†If weight is replaced by BSA, the R2 values are very similar for all 3 models.
‡Liver fraction is remnant/total size, centered on 50%.
§In the recipient model, donor and recipient sex, age, height, BMI, and BSA; donor weight; graft lobe type (left or right),
GRWR, liver fraction, and cold ischemia time; and recipient SLV, HCV diagnosis, and MELD score at transplant were tested
but were not significant.
jjOne recipient missing weight was excluded from recipient and combined models. One recipient missing height (needed to
calculate SLV) was also excluded from the combined model.
¶In the combined model, lobe type (left or right; remnant for donor, graft for recipient) and liver fraction were tested but
were not significant, as were interactions between donor and all factors.
#Restricted to 106 donors and 128 recipients with remnant or graft liver volume (of 550-1200 g), which included 48% of
remnant lobes and 85% of donated lobes.
Figure 2. Box and whisker plot of liver volume before and after
transplant. The bottom and top of boxes indicate the 25th and
75th percentiles, respectively; middle line indicates the median,
and a plus sign indicates the mean. Whiskers extend up to 1.5
times the IQR from the bottom and top edges of the box, ending
at the last actual data point within the range.
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months (80% of starting TLV versus 93% of expected
SLV, P<0.001; Figs. 2 and 3A,B). Only 14 donors
(6.3%) achieved 100% of starting TLV by 3 months,
whereas 52 (36%) recipients achieved their calculated
SLV. Percentage volume increase of the remnant liver
showed a wide range in both donors (median 119%,
Q1586%, Q35176%) and recipients (median 55%,
Q1536%, Q3579%, P<0.001). At 3 months, liver
volume was smaller for 211 right lobe than 10 left
lobe donors (12336265 cc versus 14136361 cc,
P50.04). Nevertheless, donors of right lobes (who had
smaller remnants) had more absolute volume increase
than donors of left lobes; recipient growth was compa-
rable, regardless of lobe (Supporting Fig. 2A). Left lobe
donors had a higher percentage reconstitution than
right lobe donors. Among recipients, right lobe grafts
were significantly larger than left lobe grafts at
3 months (15536302 cc versus 12256166 cc,
P50.02). Recipient liver reconstitution was compara-
ble for the 2 lobes (Supporting Fig. 2B).
Predictors of 3-Month Volume: Donors and
Recipients
Among donors, greater body weight, TLV, and liver
fraction were significantly and positively associated
with greater 3-month liver volume (Table 2). When
adjusted for these 3 measures, neither remnant vol-
ume nor lobe donated had a statistically significant
effect on 3-month volume. On average, liver volume
at 3 months was 43.8 cc higher for every 10 kg of
donor body weight (P<0.001) and 51 cc higher for
every 100 cc of original TLV (P<0.001); the latter is
demonstrated in Fig. 4, which shows the predicted 3-
month liver volume for donors with 3 different TLVs
for remnant liver fractions between 0.2 and 0.7,
accounting for 87.3% of donors. The relationship
with liver fraction was not linear; 3-month liver vol-
umes were similar for remnant liver fractions
between 0.2 and 0.5, with increasing 3-month vol-
umes for liver fractions >0.5.
Recipient body weight and graft size were posi-
tively and significantly associated with 3-month liver
volume (Table 2). Liver volume at 3 months was on
average 71 cc higher for every 10 kg of recipient
weight (P<0.001) and 60 cc higher for every 100 cc
of transplanted graft weight (P<0.001). Unlike the
donors, the relationship between starting liver frac-
tion and 3-month liver volume was linear, without
the parabolic tail seen for the smaller remnants
(P50.42).
We tested weight, continuous BMI, and BMI catego-
ries (normal, overweight, and obese) in donors and
recipients for all measures of regeneration. In both
donor and recipient models, we found weight to be
the stronger predictor of regeneration as measured by
3-month volume in donors and recipients and abso-
lute volume increase in the donors. After adjusting for
weight, BMI provided no additional predictive infor-
mation. We assessed the influence of HCV, hepatocel-
lular carcinoma, and diabetes on liver growth. None of
these variables were significantly associated with
parameters of liver regeneration.
Figure 3. (A) Donor and recipient absolute growth at 3 months
by lobe. (B) Donor and recipient percentage liver reconstitution
at 3 months by lobe. Each regeneration measure is based on
remnant lobe for donors and on transplanted lobe for recipients.
The bottom and top of boxes indicate the 25th and 75th percen-
tiles, respectively; middle line indicates the median, and a plus
sign indicates the mean. Whiskers extend up to 1.5 times the
IQR from the bottom and top edges of the box, ending at the last
actual data point within the range.
Figure 4. Predicted donor liver volume at 3 months (y axis) and
remnant liver fraction (x axis) at transplantation based on donor
model. Predicted values are shown for 3 hypothetical 78-kg
donors with TLV of 1300, 1550, and 1800 cc.
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Previous reports have used 3 additional measures of
liver growth to assess liver regeneration: absolute
growth, percentage volume increase, and percentage
reconstitution. The significant predictors for these
outcomes were liver fraction (all outcomes), remnant/
graft size (percentage reconstitution), and donor/
recipient weight (percentage reconstitution and abso-
lute volume increase). In addition, the following
donor/recipient variables were tested and found to
not be significant. For donors: sex, age, BMI, and
graft type (left/right lobe). For recipients: graft type
(left/right lobe), SLV, sex, age, BMI, HCV, hepatocellu-
lar carcinoma, diabetes, MELD score, cold ischemia
time, and donor age, sex, and BMI. Thus, the main
predictors of liver regeneration, no matter how they
are measured, are remnant/graft size, liver fraction,
and weight.
Predictors of 3-Month Volume: Combined
Donors and Recipients
Predictors of 3-month liver volume in 106 donors and
128 recipients were examined over the range of com-
mon lobe weights (550-1200 g; Table 2). Positive asso-
ciations with 3-month donor and recipient volumes
were seen for donor or recipient weight, remnant or
graft volume, and donor TLV. The effects of these 3
features were similar for donors and recipients, with
no significant interaction between patient type and
any of these factors. Most importantly, we found that
after adjustments for these factors, 3-month volumes
were greater for recipient than for donor livers by
110 g on average (P50.004).
Paired Comparisons Between Lobes
Donor and recipient data were complete for 127 pairs.
There was no correlation between the liver lobes for
absolute growth (r520.1, P50.28), percentage
reconstitution (r520.14, P50.11), or percentage vol-
ume increase (r520.07, P50.46). There was a signif-
icant correlation between 3-month volumes for these
pairs (r50.26, P50.003) that was lost when adjusted
for donor TLV (r520.03, P50.73).
Clinical Correlates
Correlation of Recipient Regeneration With Graft
Function and Failure
Twenty-four recipients died or lost their graft in the
first 90 days. Forty-nine recipients (44 right lobes, 5
left lobes) had early allograft dysfunction and symp-
toms of SFSS (16% overall; 15% of right lobe, 29% of
left lobe recipients). Among them, 38 (34 right lobes,
4 left lobes) survived for at least 90 days with a func-
tioning graft. Poor graft function at day 7 predicted
progression to graft failure both overall (HR52.5,
P50.004) and in the first 90 days following trans-
plantation (HR54.5, P50.001).
Ten of 12 recipients with GRWR <0.8% or graft frac-
tion <40% survived for at least 90 days with a func-
tioning graft. Neither GRWR nor graft fraction was
associated with graft failure overall or in the first 90
days or with poor function at day 7. Adjusted for graft
size and patient weight, grafts with dysfunction at 1
week (with 3-month imaging) were a mean of 140 cc
larger at 3 months (P50.02) than those without early
dysfunction.
There were only 15 graft failures beyond 3 months,
and none of the measurements of liver regeneration
(3-month volume, absolute or percentage volume
increase, or percentage reconstitution) were signifi-
cantly associated with subsequent graft failure. How-
ever, this result must be considered in light of the low
statistical power.
Correlation With Laboratory Values in Donors
and Recipients
For donors (Table 3), remnant fractions correlated
with 7- and 30-day bilirubin and INR and 30-day
TABLE 3. Clinical Correlates of Donor Remnant Fraction and Recipient Graft Fraction
Donor Remnant Fraction Recipient Graft Fraction
Laboratory value r P Value r P Value
Day 7 after donation
Bilirubin 20.13 0.02 0.03 0.61
INR 20.13 0.03 20.27 <0.001
Albumin 0.09 0.13 0.004 0.95
Creatinine 0.05 0.37 0.03 0.63
Day 30 after donation
Bilirubin 20.12 0.03 0.005 0.93
INR 20.13 0.03 0.01 0.88
Albumin 0.18 0.002 0.13 0.04
Creatinine 0.22 0.0001 0.007 0.91
1 year after donation
Platelet drop since evaluation 20.13 0.08 — —
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albumin and creatinine. Bilirubin at 7 days after don-
ation correlated with liver volume at 3 months
(r50.19, P50.004). Platelet counts decreased from
evaluation to year 1 after donation more for donors
with smaller remnants (Table 3). Compared with left
lobe donors, right lobe donors had significantly higher
bilirubin at days 7 and 30 and lower albumin at 30
days (3.8 versus 4.1, P50.006; Supporting Table 1).
Among recipients, significant correlations with graft
liver fractions were seen for 7-day INR and 30-day
albumin (Table 3). Liver volume at 3 months was also
correlated (P<0.05) with bilirubin and creatinine at 7
days after transplantation, and albumin and creati-
nine at 30 days after transplantation.
We also correlated laboratory values (bilirubin, albu-
min, and INR) with the 3 measures of liver regenera-
tion (absolute and percentage volume increase, and
percentage reconstitution) for donors and recipients.
For donors, the only significant correlation was
between day 7 bilirubin and absolute volume
increase. For recipients, day 7 bilirubin was consis-
tently correlated with liver regeneration, and INR was
correlated with 2 of the regeneration measures (Sup-
porting Table 4).
DISCUSSION
In living donor transplantation, donor and recipient
livers need to regenerate while maintaining adequate
metabolic function. This process is central to donor
safety and to avoiding liver dysfunction in the recipi-
ent.7,18,19 The current study confirms previous obser-
vations that regeneration was brisk in donors and
recipients, with substantial, though not always com-
plete, mass restoration by 3 months.14,20 A unique
aspect of this study is that this is the first multicenter
study of the clinical manifestations of liver regenera-
tion in LDLT in the West. Using a prospectively
defined clinical cohort, we were able to characterize
growth patterns common to donors and recipients,
despite the vagaries of local surgical practice.
An important finding is the apparent relationship
between donor regeneration and both TLV and rem-
nant liver fraction. Uncertainty remains within the liv-
ing donor community regarding the minimum
remnant liver size in the donor, with proposed lower
limits between 25% and 35% of total volume. Though
right lobes and left lobes differed markedly with
respect to both graft size and remnant liver volume,
they appear to regenerate in a similar pattern. Impor-
tantly, donor remnant size is a critical predictor of the
rate of regeneration. Regeneration in donors was
related to body weight, predonation total liver volume,
and fraction of total liver remaining after donation,
regardless of lobe used, which aligns with recent find-
ings by others. Klink et al.21 recently reported on
regeneration in 47 donors followed up to 84 months.
Regeneration at 1 year was 87.3% for right lobes and
80% for left lobes. No serious complications were
observed in long-term follow-up. Early regeneration
was assessed by Gruttadauria et al.5 in a series of 70
right lobe donors. Their modeling identified greater
BMI, a smaller functional liver volume (FLV), and a
higher ratio of SLV/FLV as positive predictors of
regeneration. In a series of 101 cases of LDLT, Tane-
mura et al.22 identified donor age as a significant pre-
dictor of regeneration, an observation not made in our
study.
Interestingly, analyses of regeneration in donor-
recipient pairs did not show any correlation in the
regeneration parameters between the 2 parts of the
same liver, and this indicates that the host plays a
significant role in driving the process. In A2ALL, sig-
nificant numbers of the donors had less than 35%
calculated residual volume, all after right lobe resec-
tion. We demonstrated a parabolic relationship in
donors between 3-month volume and remnant frac-
tion, with the smallest remnants regenerating faster.
Despite very rapid regeneration, early postoperative
hepatic function, as measured by bilirubin, INR, and
albumin, was compromised with very small remnant
liver size, demonstrating an association between liver
mass and function.23-25 Avoidance of very small rem-
nants in donors is one element supporting the trend
toward greater use of the left lobe in LDLT to minimize
the extent of hepatectomy.
Recipients also demonstrated rapid regeneration,
achieving 93% of calculated SLV by 3 months. Larger
recipients and those who received a larger graft had
greater volume at 3 months. Unlike the donors, a
smaller fraction of SLV was not associated with
3-month liver volume, possibly because of SLV being
only a rough approximation of original liver size. With
regard to function, smaller grafts had higher INR at 1
week and 1 month.
A unique contribution of our study is the compara-
tive analysis of liver growth between the donor and
the recipient. In a combined model of donors and
recipients, patient weight, larger starting liver volume
(remnant or graft), larger TLV or SLV, and patient type
(donor versus recipient) each significantly predicted
3-month liver volume. We demonstrated that recipient
liver grafts grew more rapidly in the first 3 months
than the donor remnants. This recipient-donor diver-
gence did not appear to be due to the variations in the
starting lobe size; we demonstrated that, in recipients
and donors with similar graft or remnant sizes, the
recipient liver growth was greater. Fewer donors
achieved their baseline liver volume than recipients
who achieved their predicted liver volumes by 3
months. Only 6.3% of donors achieved 100% of start-
ing TLV, whereas 35% of recipients achieved 100% of
SLV. Others have noted related observations,4 which
likely reflect the very distinct physiology between
donors and recipients. We speculate that the ischemic
stress and metabolic demands in recipients provide a
growth stimulus to activate priming cytokines for ini-
tiation of liver regeneration, whereas the donor has
less metabolic demand and no immune pressure or
other obvious outward regenerative enhancing stim-
uli. The relative illness of the recipient may be an
impetus for more rapid growth resulting from higher
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metabolic demand.26 Both mechanisms are clinically
plausible, shifting the energy balance of the recipient
toward faster and greater growth than that in the
donor. Finally, it is possible that the larger size of the
recipient livers may not reflect “normal” hepatocyte
mass but perhaps increased water content or other
metabolic alterations of the recipient parenchyma
compared with the regenerating donor tissue. Our
ongoing mechanistic studies in liver regeneration may
provide supporting molecular evidence for these find-
ings. Recognizing these differences in magnitude of
regeneration, we also demonstrated some commonal-
ities between donor and recipient in that donor and/
or recipient weight, TLV, and/or SLV, as well as rem-
nant liver and/or graft volume were all predictors of
3-month volume.
Several large studies, including A2ALL, have shown
that older recipients, greater donor age, cold ischemia
time, MELD score, and graft size affect outcome.2,13,27
There is evidence that small liver grafts transplanted
into a metabolically stressed recipient, eg, those in the
ICU, those with fulminant failure, renal failure, and
high MELD scores, have less favorable outcomes than
those transplanted into the more advantageous envi-
ronment of a healthier recipient.26,28 However, several
recent studies have shown that smaller grafts can be
used effectively if other parameters are carefully man-
aged or limited, such as donor and recipient age or the
presence of significant portal hypertension.16,17 Others
have shown that it is possible to transplant success-
fully patients with higher MELD scores with living
donors if carefully selected.29,30 In this current study,
we did not observe an effect of MELD on regeneration,
but there were very few subjects with high MELD
scores, and this warrants further investigation.
We were also unable to demonstrate a relationship
between any of the regeneration parameters and graft
loss in this cohort. Early graft dysfunction, as evi-
denced by persistent jaundice or coagulopathy at day
7, was seen in 16% of recipients, with more left lobe
recipients displaying these features (29% versus
15%). In addition, poorly functioning grafts were 2.5
times more likely to have subsequent graft failure.
However, we did not observe a correlation between
postoperative graft failure and graft size, and this sug-
gests that early graft dysfunction is dependent on a
combination of factors. Identifying these other factors
will be important for extending the limits of donation
in the future and is a continued focus of A2ALL.
We recognize the limitations of this study, which
resulted primarily from missing volumetric data in a
significant percentage of patients. In addition, clinical
variables that we did not collect, such as variables
that better define poor graft function or intraoperative
physiologic measurements such as portal pressures
and flows, may affect regeneration. The study of
regeneration in vivo depends on the reliability of
image-based volumetry of the liver and presents
numerous challenges, including prediction of the pro-
jected graft based on an imaged transection line, the
normal variation of the ratio of liver size to body
weight or surface area, and the shape and relative
lobar volumes. We also noted significant center varia-
tion in measurement discrepancies. Although others
have used differing approaches,10,31-34 we estimated
the volume of blood in the liver as a linear relation-
ship between the in vivo volume and the weight of the
resected lobe, not forced to pass through the origin.
In conclusion, current practice in adult-to-adult
LDLT is well within the limits of safe regeneration for
both donors and recipients. Thus, it should be possi-
ble to move farther by understanding how the quality
of the parenchyma, the size of the remnant lobe and
the graft, and the status of the recipient affects early
regeneration and function. Certainly, the error and
variability in measuring liver volume in vivo must be
considered when we are evaluating a potential donor-
recipient pair to determine the residual remnant frac-
tion and graft volume. Better definitions of these
parameters and limits will lead to expanded use of
adult LDLT. To this end, mechanistic studies of bio-
markers associated with regeneration are ongoing
with specimens collected from these A2ALL subjects.
Because LDLT provides a laboratory to observe liver
growth in the human setting, it is important for the
research community to use this unique opportunity to
study biological interventions that may enhance liver
growth and improve liver function.
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